Y.B Urban Renewal - Residential Development LTD Logo

Y.B Urban Renewal - Residential Development LTD

A company focused on urban renewal projects and residential development initiatives.

CSURE-M | TA

Overview

Corporate Details

ISIN(s):
IL0001110134
LEI:
Country:
Israel
Address:
2 Hahadarim Street, 7712102 Ashdod

Description

Y.B Urban Renewal - Residential Development LTD is a company focused on urban renewal projects. Formerly known as Cannassure Therapeutics Ltd, the company has transitioned from the medical cannabis sector. Its current mission is to facilitate the economic, cultural, and environmental renewal of inner-city areas through residential development initiatives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 19:43
Trading in the company's shares (ISIN IL0001110134) will be renewed on Monday, …
Hebrew (modern) 113.5 KB
2025-05-05 15:53
The securities not included in the Illiquid list as of May 4th 2025 due to mar…
Hebrew (modern) 217.1 KB
2025-05-05 11:32
Suspension of trading due to failure in publication of financial reports s for …
Hebrew (modern) 79.7 KB
2025-04-28 18:40
Securities that have joined the program and the Market Makers that will operate…
Hebrew (modern) 366.8 KB
2025-04-20 18:21
Failure in publishing financial reports-Notification
Hebrew (modern) 128.0 KB
2025-03-06 18:39
Illiquid Candidates securities list as of May 4th 2025
Hebrew (modern) 245.6 KB
2024-07-28 18:05
The company's securities will be transferred from the maintenance list to the m…
Hebrew (modern) 106.5 KB
2024-07-11 17:14
Changes in the company's share symbol correction: YBRD-M
Hebrew (modern) 104.0 KB
2024-07-09 17:01
Changes in the company's name and security, effective as of July 11, 2024
Hebrew (modern) 105.9 KB
2024-06-25 19:48
Changes in Sector Classification of Listed Companies as of Sunday, June 30, 2024
Hebrew (modern) 135.9 KB
2024-03-21 18:45
Will trade on Monday March 25 2024, with unlimited price fluctuation at the ope…
Hebrew (modern) 137.2 KB
2023-07-13 20:43
Transfer to the Maintenance List on July 17, 2023
Hebrew (modern) 149.7 KB
2023-07-03 19:48
Companies that do not comply with the Maintenance Rules and are candidates to b…
Hebrew (modern) 116.3 KB
2023-01-15 17:37
Non-Compliance with the Maintenance Rules Based on Data as of December 31, 2022…
Hebrew (modern) 132.9 KB
2021-01-07 15:45
On Sunday, 10 January 2021, trading will commence in the following Security: CA…
Hebrew (modern) 186.1 KB

Automate Your Workflow. Get a real-time feed of all Y.B Urban Renewal - Residential Development LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Y.B Urban Renewal - Residential Development LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Y.B Urban Renewal - Residential Development LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.